As FDA praises manufacturer plan...

Legal Experts Tout Need For More FDA Authority To Respond To Drug Shortages

October 24, 2014 at 1:53 PM
Legal experts say Congress should give FDA new power to respond to shortages of critical drugs, floating the ideas of letting FDA temporarily re-purpose a drug license to another company, akin to NIH's march-in rights, and allowing importation from unregistered foreign manufacturers. The suggestions came a week after pharmaceutical engineers released a manufacturer-spearheaded drug shortage prevention plan that drew some praise from FDA and European regulatory officials. Charleston School of Law Professor William Janssen discussed the re-purposing idea at a...


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.